Navigation Links
Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
Date:4/24/2008

- Findings Published in the British Journal of Hematology -

FREMONT, Calif., April 24 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML) today reported findings from an Ohio State University (OSU) clinical study that indicated that a surface-enhanced laser desorption/ionization time of flight (SELDI-TOF)-based thrombotic thrombocytopenic purpura (TTP) diagnostic test could be used to help estimate the risk of TTP relapses during clinical remission. OSU currently offers the TTP test as a laboratory developed test, based on an exclusive licensing agreement with Vermillion, and for which Vermillion sells OSU supplies and laboratory reagents.

The data -- published recently in the online edition of the British Journal of Haematology -- indicate that use of the test may provide a novel screening strategy to identify patients who may benefit from prophylactic treatment to help prevent relapse of this serious blood disorder. TTP is caused by a deficient activity of the enzyme ADAMTS13, which leads to platelet clumping, red blood cell destruction, and, in serious cases, to neurological abnormalities and renal failure.

"TTP is a life-threatening disease that affects thousands of people each year. The disease is characterized by frequent recurrences, with approximately half of all patients experiencing relapses," said Haifeng M. Wu, M.D., lead investigator of the study and Assistant Professor of Pathology and Medicine and Director of the Clinical Coagulation Laboratory at OSU Medical Center. "The SELDI-TOF technology was instrumental in improving sensitivity for extremely low levels of ADAMTS13, which may be used to help identify patients who could be candidates for prophylactic treatment based upon their increased ri
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
6. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
7. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
8. Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges
9. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... , Aug. 5, 2015 CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today that ... Annual Growth Conference on Wednesday, August 12, 2015 at ... A live webcast of the Company,s presentation is scheduled ... overview of the company by Pat Mackin , President ...
(Date:8/5/2015)... -- Ardelyx, Inc. (NASDAQ: ARDX ), a clinical-stage biopharmaceutical ... that Mike Raab , Chief Executive Officer, will ... PacGrow Healthcare Conference at 12:45 p.m. Eastern Time on ... New York City . The ... accessible through a link in the Investor Relations section ...
(Date:8/5/2015)... 5, 2015 LifeBond ... medical devices for tissue repair, announced today it ... investment. Participants in the round include Pitango Venture ... all existing investors.      (Logo: http://photos.prnewswire.com/prnh/20140929/708770) ... introduction and commercialization in the European Union of ...
Breaking Medicine Technology:CryoLife to Present at Canaccord Genuity 35th Annual Growth Conference 2Ardelyx to Present at the 2015 Wedbush PacGrow Healthcare Conference 2LifeBond Closes $27 Million Series D Financing Round 2LifeBond Closes $27 Million Series D Financing Round 3
... MedShape Solutions, Inc., the industry leader in innovative ... DynaNail™ Intramedullary Ankle Fusion Nail. Ankle fusion is ... degenerative ankle joints, to correct joint deformities or ... unique, patented design utilizes shape memory alloy technology ...
... Aug. 9, 2011 Reportlinker.com announces that ... in its catalogue: Medical ... Trends - Q2 2011 ... Quarterly Deals Analysis: M&A and Investment Trends ...
Cached Medicine Technology:MedShape Solutions Announces FDA 510(k) Clearance of Innovative Ankle Fusion Device 2MedShape Solutions Announces FDA 510(k) Clearance of Innovative Ankle Fusion Device 3Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 2Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 3Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 4Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 5Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 6Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 7Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 8Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 9Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 10Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 11Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011 12
(Date:8/5/2015)... ... August 05, 2015 , ... Available in select spas and ... with a quartet of beauty-enhancing marine and plant oils. A perfect complement to Phytomer’s ... which stands out for its lovely scent and soothing properties. Formulated as a light ...
(Date:8/5/2015)... ... August 05, 2015 , ... Over 6,500 athletes from 177 nations recently descended ... the Special Olympics World Games 2015 (July 25 to August 2). , Officially opened ... in Los Angeles since the 1984 Olympics, and the Los Angeles Coliseum was once ...
(Date:8/4/2015)... New York (PRWEB) , ... August 05, 2015 ... ... would allow a Texas-based corporation, Crestwood Midstream, to store liquid propane gas (LPG) ... East, the powerful healthcare workers union, unanimously passed a resolution that strongly opposes ...
(Date:8/4/2015)... NY (PRWEB) , ... August 05, 2015 , ... ... honors Deborah Stevens as a 2015-2016 inductee into its VIP Woman ... in business. NAPW is the nation’s leading networking organization exclusively for professional women, ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Statement by Paul ... the introduction of the Mental Health Reform Act of 2015 by Senators ... mental health reform a reality in America. , “This legislation and H.R. ...
Breaking Medicine News(10 mins):Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4Health News:CPMA Member Podiatrists Ensure Fit Feet at the Special Olympics World Games in Los Angeles 2Health News:CPMA Member Podiatrists Ensure Fit Feet at the Special Olympics World Games in Los Angeles 3Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 2Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 3Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3
... A study in the September issue of Archives of Pediatrics ... kids aged 12 to 17 in the US may have ... other despite a ban on tobacco advertising in 2001 to ... still prevalent in movie trailers. ,"Trailers pair tobacco ...
... biochemical step that many disease-causing bacteria use to build ... promise for effective, new antibiotics against these bacteria, according ... finding is significant because the biochemical step the antibiotic ... a drug would not cause dangerous side effects. ...
... to experts at the World Congress of Cardiology, a ... This ‘polypill’ could save lives of millions of people//especially ... ,Aspirin, statins and ACE inhibitors are the three ... other cardiovascular health problems are known to be prevented ...
... the psychosocial effects of cleft lip and/or palate among ... predictor of behavioral problems. This study is published in ... ,The study included 160 children and young adults with ... no clefting. Anxiety, self-esteem, depression, behavioral problems, unhappiness with ...
... Experts from Spain are not too comfortable with the ... a saving grace//, could carry a risk of formation of ... market in 2000 as an upgraded version of bare-metal stents. ... people worldwide have the drug-lined versions of the stents, which ...
... at Harvard University have identified key compounds that stimulate ... researchers whose findings, is set to appear in the ... this discovery might one day lead to restored function ... Parkinson's, strokes, multiple sclerosis, and a wide range of ...
Cached Medicine News:Health News:Tobacco Advertising Through Movies Luring Kids 2Health News:Solution to Bacterial Mystery Promises New Drugs 2Health News:“Polypill”- to prevent recurrent heart diseas 2
... offers a complete line of flowmeters, ... CO 2 . They are all ... to best suit your application. With ... to the gas in use, the ...
... Amvex offers a complete line of ... and CO 2 . They are ... calibrations to best suit your application. ... specific to the gas in use, ...
... Amvex offers a complete line of flowmeters, available in ... all available in a variety of calibrations to best ... specific to the gas in use, the Amvex Flowmeter ... replace the U with I. For Power Take-Off add ...
... flowmeters, available in oxygen, air, heliox and CO 2 ... calibrations to best suit your application. With color coded ... the Amvex Flowmeter is a user friendly device., ... Power Take-Off add PT to the end of the ...
Medicine Products: